People who use Zepbound or Mounjaro, the dual-agonist medications, lose an average of about 20% of their body weight, while those who take Ozempic or Wegovy, the single-agonist drugs, lost an average of about 14% of their body weight
Controlled human data is more limited, which is why it remains a research-use compound in most jurisdictions the gap between animal and human evidence is its most-cited limitation
V., Mingrone, G., Bianchi, M., and Ghirlanda, G
Calculating doses on a syringe from a 5mg vial Syringe math intimidates new researchers, but it follows a simple formula
I've been on both sides of it: I've watched people I love relapse, and I've been the one people were trying to reach when I went back out after seven and a half years
That means a teen could: Lose eligibility Be removed from a team Face long-term consequences for their athletic and academic future There are rare exceptions for medically necessary prescriptions